Dr. Sardar Imam
Claim this profileGSK Investigational Site
Studies Tumors
Studies Squamous Cell Carcinoma
4 reported clinical trials
5 drugs studied
Area of expertise
1Tumors
Stage IV
MMR positive
MMR negative
2Squamous Cell Carcinoma
metastatic
locally advanced
extensive stage
Affiliated Hospitals
Clinical Trials Sardar Imam is currently running
TSR-022
for Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting1 award Phase 1
Dostarlimab
for Advanced Cancer
This trial is testing dostarlimab, a medicine that helps the immune system fight cancer, in patients with advanced solid tumors who have limited treatment options. It works by blocking a protein that allows cancer cells to hide from the immune system. Dostarlimab has garnered extensive interest for its ability to activate the immune system to respond to cancer cells.
Recruiting1 award Phase 110 criteria
More about Sardar Imam
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sardar Imam has experience with
- Dostarlimab
- TSR-022
- Pembrolizumab
- Ladiratuzumab Vedotin
- SEA-CD70
Breakdown of trials Sardar Imam has run
Squamous Cell Carcinoma
Esophageal Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sardar Imam specialize in?
Sardar Imam focuses on Tumors and Squamous Cell Carcinoma. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are MMR positive.
Is Sardar Imam currently recruiting for clinical trials?
Yes, Sardar Imam is currently recruiting for 3 clinical trials in Farmington New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Sardar Imam has studied deeply?
Yes, Sardar Imam has studied treatments such as Dostarlimab, TSR-022, Pembrolizumab.
What is the best way to schedule an appointment with Sardar Imam?
Apply for one of the trials that Sardar Imam is conducting.
What is the office address of Sardar Imam?
The office of Sardar Imam is located at: GSK Investigational Site, Farmington, New Mexico 87401 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.